L. Roy Papp & Associates’s Celgene Corp CELG Stock Holding History

L. Roy Papp & Associates’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,530	Closed	-$1.64M	–	181
2019 Q3	$1.64M	Hold	16,530	–	–	0.26%	77
2019 Q2	$1.53M	Buy	16,530 +11,630	+237%	+$1.1M	0.24%	80
2019 Q1	$462K	Hold	4,900	–	–	0.08%	112
2018 Q4	$314K	Hold	4,900	–	–	0.07%	123
2018 Q3	$439K	Hold	4,900	–	–	0.08%	117
2018 Q2	$389K	Sell	4,900 -200	-4%	-$16.6K	0.07%	119
2018 Q1	$455K	Buy	5,100 +1,700	+50%	+$163K	0.09%	118
2017 Q4	$355K	Buy	3,400 +2,000	+143%	+$226K	0.07%	122
2017 Q3	$204K	Buy	+1,400	New	+$191K	0.04%	129

Other funds holding CELG

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

L. Roy Papp & Associates's CELG Position: Q4 2019 in Review

L. Roy Papp & Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,530 shares — an estimated $1.64M sold.

L. Roy Papp & Associates first reported a position in CELG in Q3 2017 and held it in 9 quarters. The position peaked at $1.64M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

L. Roy Papp & Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
L. Roy Papp & Associates sold 16,530 Celgene Corp shares in Q4 2019, an estimated $1.64M.
L. Roy Papp & Associates first reported a position in Celgene Corp in Q3 2017 and held it in 9 quarters.
L. Roy Papp & Associates's Celgene Corp position peaked at $1.64M in Q3 2019.
3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on L. Roy Papp & Associates's 13F filing for Q4 2019, filed 14 Feb 2020.